Drug Trial Radar · NCT03981536
A Study to Evaluate AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)
Last checked: Nov 19, 2026Latest source record: Oct 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
18
Planned (sponsor's estimate)
Start
Oct 10, 2019
Primary completion
Nov 2, 2020
Study completion Nov 2, 2020
Sponsor
- Lead sponsor
- AL-S PharmaIndustry
- Sponsor type
- Industry
- First posted
- Jun 11, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Single ascending doses of AP-101 will be administered by intravenous (IV) infusion
Conditions
- Amyotrophic Lateral Sclerosis
Interventions
AP-101Drug
Administered by intravenous infusion (IV)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With One or More Non-Serious Adverse Events (AEs) or Any Serious AEs (SAEs)Time frame: Baseline up to day 84
- Number of participants with abnormalities in vital signs, clinical laboratory assessments, physical or neurological examinations, or electrocardiograms (ECGs)Time frame: Baseline up to day 84
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
London Health Sciences Centre, University Hospital
London, Ontario, Canada
Sunnybrook Health Sciences Centre, Toronto
Toronto, Ontario, Canada
Montreal Neurological Institute & Hospital
Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.